Cheung et al.10found that overexpression of CRKL triggered gefitinib resistance in epidermal growth factor receptor (EGFR)‐mutant cells via actuating AKT signaling and extracellular signal‐regulated kinase in non‐small cell lung cancer. Here, AKT1 is linked to lung cancer.